But kids still don't see nicotine as addictive and may opt for e-cigarettes instead
Parents, doctors may not recognize infantile spasms early enough to prevent brain damage, study finds
Cannabidiol lowered frequency, severity of seizures in trials, but without a 'high'
Study suggests patient care info might not be relayed to new team, boosting risk of in-hospital death
Too little shut-eye can equal alcohol in terms of impairment behind the wheel, traffic safety group warns
By Ben Hirschler LONDON (Reuters) - These days the average researcher at Philips is more likely to be a software developer than an product engineer, reflecting a transformation at the former Dutch conglomerate that its chief executive says will gather pace. "It's a huge shift," Frans van Houten told Reuters, noting that around 60 percent of the healthcare technology company's R&D staff are now focused on software. It will not go to 100 percent, because we will still make products, but you could easily see that the value-add comes more out of software than hardware." Philips has repositioned itself as a health business after spinning off lighting, which has freed up capacity for acquisitions such as last year's $1.2 billion purchase of blood vessel imaging firm Volcano.
Britain's competition watchdog has fined Pfizer a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium capsules, following a dramatic price hike in 2012. The CMA's ruling comes amid a growing debate on both sides of the Atlantic about the ethics of price hikes for old off-patent medicines that are only made by a few firms and where there is little competition.
By Daria Sito-Sucic SARAJEVO (Reuters) - Bosnian banks, food producers and hoteliers are adopting halal standards to tap a fast-growing market thanks to the country's large Muslim population, an influx of Gulf tourists and growing trade with the Arab world. Bosnia has one of Europe's largest indigenous Muslim populations, traditionally liberal in its interpretation of Islam, but the arrival of Arab fighters during the 1992-95 war and an influx of Saudi money has spurred an Islamic revival. The country, half of whose population is Muslim, has become a regional hub for halal products since it set up Europe's first agency for halal quality certification in 2006.
Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Wednesday the U.S. health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection. The approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plant in the western Indian state of Gujarat. A warning letter issued by the U.S. Food and Drug Administration (FDA) last year over violations found at the plant has already been hurting the company's sales.